Brandvent Asia Pacific: Pioneering Digital Outdoor Advertising in India and Healthcare Expansion

Bihar (India), October 26: Brandvent Asia Pacific, a prominent player in the digital outdoor advertising sector, has been making significant strides in the industry since its inception in 2016. Today, it proudly holds the distinction of being the largest digital outdoor advertising agency in India.

Dr. Abhinav, the founder of Brandvent Asia Pacific, is an accomplished entrepreneur with a strong educational background. He graduated from the renowned Welham Boys’ School in Dehradun and pursued his MBBS degree. Dr. Abhinav then specialized in ENT and head and neck surgery. He comes from a long line of doctors, spanning four generations, which has played a significant role in shaping his commitment and knowledge. This rich background has greatly contributed to his success in establishing and leading Brandvent Asia Pacific in the digital outdoor advertising industry.

With an impressive roster of clients that includes global giants such as PepsiCo, Hero MotoCorp, Maruti Suzuki, and Yamaha, Brandvent has solidified its position as an industry leader in digital outdoor advertising. Their campaigns have consistently demonstrated a deep understanding of their clients’ brands, effectively conveying their unique messages to a vast audience.

In 2019, Brandvent took its expertise into the realm of politics, actively participating in the Bihar Legislative Assembly elections. This venture showcased the agency’s capabilities in devising data-driven campaigns that played a pivotal role in shaping public opinion and influencing the political landscape.

In a notable expansion move, Brandvent ventured into the healthcare sector by establishing Venture Diagnostics in 2021. This healthcare venture quickly gained recognition for its proficiency, having completed over 20,000 blood tests with a focus on accuracy and reliability. Furthermore, Brandvent has ambitious plans to enter the online pathological service sector, targeting full-scale expansion by January 2024. Their objective is to complete one million tests by 2025. This endeavor is now under the umbrella of Vento Healthcare.

Brandvent’s commitment to innovation remains a cornerstone of its operations. Whether it’s creating captivating outdoor digital advertisements or ensuring the precision of medical diagnostics, innovation is deeply embedded in the agency’s approach. Their dedication to pushing the boundaries of what’s possible is evident in all aspects of their work.

As Brandvent Asia Pacific continues to evolve and diversify, it is poised to redefine industry benchmarks in both the advertising and healthcare sectors. The agency’s commitment to excellence, creativity, and innovation is setting a new standard for the digital and healthcare landscapes. Watch this space for more developments as Brandvent continues to make waves in Bihar and beyond.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More